rsu.dxtest: Sensitivity and specificity of diagnostic tests interpreted...

View source: R/rsu.dxtest.R

rsu.dxtestR Documentation

Sensitivity and specificity of diagnostic tests interpreted in series or parallel

Description

Calculates the sensitivity and specificity of two or three diagnostic tests interpreted in series or parallel.

Usage

rsu.dxtest(se, sp, covar.pos, covar.neg, interpretation = "series")

Arguments

se

a vector of length two or three defining the diagnostic sensitivity of the two or three tests.

sp

a vector of length two or three defining the diagnostic specificity of the two or three tests.

covar.pos

a vector of length either two or four defining the covariance between test results for the disease positive group. For two diagnostic tests covar.pos is a vector of length one. For three diagnostic tests covar.pos is a vector of length four listing (in order) the covariance between test 1 and 2, test 1 and 3, test 2 and 3 and tests 1, 2 and 3. See the examples, below for details.

covar.neg

a vector of length either two or four defining the covariance between test results for the disease negative group. For two diagnostic tests covar.neg is a vector of length one. For three diagnostic tests covar.neg is a vector of length four listing (in order) the covariance between test 1 and 2, test 1 and 3, test 2 and 3 and tests 1, 2 and 3. See the examples, below for details.

interpretation

a character string indicating how the test results should be interpreted. Options are series or parallel.

Value

A list comprised of two elements:

independent

a data frame listing sensitivity se and specificity sp assuming the tests are independent.

dependent

a data frame listing sensitivity se and specificity sp calculated using the values of covar, as entered by the user.

If covar.pos = 0 and covar.neg = 0 (for the two test situation) data frames independent and dependent will be identical.

Note

For the two test situation covar.pos is a vector of length one quantifying the covariance between between the two tests for the disease positive group. For the three test situation covar.pos is a vector of length four listing (in order) the the covariance between test 1 and 2, test 1 and 3, test 2 and 3 and tests 1, 2 and 3 for the disease positive group:

Element Test pair
------------------ ------------------
1 Test 1 - Test 2
2 Test 1 - Test 3
3 Test 2 - Test 3
4 Test 1, 2, and 3
------------------ ------------------

For the two test situation covar.neg is a vector of length one quantifying the covariance between between the two tests for the disease negative group. For the three test situation covar.neg is a vector of length four listing (in order) the the covariance between test 1 and 2, test 1 and 3, test 2 and 3 and tests 1, 2 and 3 for the disease negative group:

Element Test pair
------------------ ------------------
1 Test 1 - Test 2
2 Test 1 - Test 3
3 Test 2 - Test 3
4 Test 1, 2, and 3
------------------ ------------------

For interpretation = "series" a subject is declared test positive if both of the tests performed return a positive result. For interpretation = "parallel" a subject is declared test positive if one of the tests performed return a positive result. Intepreting test results in series increases diagnostic specificity. Interpreting test results in parallel increases diagnostic sensitivity.

How do I work out appropriate values for covar.pos and covar.neg? Assume you have two diagnostic tests — an indirect fluorescent antibody test (IFAT) and a polymerase chain reaction (PCR). The diagnostic sensitivity and specificity of the IFAT is 0.784 and 0.951, respectively. The diagnostic sensitivity and specificity of the PCR is 0.926 and 0.979, respectively. These tests are used on a group of individuals known to be disease positive and a group of individuals known to be disease negative. Results for the disease positive group are as follows:

IFAT
----------- ---------- ---------- ----------
PCR Pos Neg Total
----------- ---------- ---------- ----------
Pos 134 29 163
Neg 4 9 13
----------- ---------- ---------- ----------
Total 138 38 176
----------- ---------- ---------- ----------

Results for the disease negative group are as follows:

IFAT
----------- ---------- ---------- ----------
PCR Pos Neg Total
----------- ---------- ---------- ----------
Pos 0 12 12
Neg 28 534 562
----------- ---------- ---------- ----------
Total 28 546 574
----------- ---------- ---------- ----------

The observed proportion of disease positive individuals with a positive test result to both tests as p111. For this example p111 = 134 / 176 = 0.761.

The observed proportion of disease negative individuals with a negative test result to both tests as p000. For this example p000 = 534 / 574 = 0.930.

Covariance for the disease positive group: covar.pos = p111 - se[1] * se[2] = 0.761 - 0.784 * 0.926 = 0.035.

Covariance for the disease negative group: covar.neg = p000 - sp[1] * sp[2] = 0.930 - 0.951 * 0.979 = -0.001.

The covariance for the disease positive group is small. The covariance for the disease negative group is negligible.

References

Dohoo I, Martin S, Stryhn H (2009). Veterinary Epidemiologic Research. AVC Inc Charlottetown, Prince Edward Island, Canada.

Gardner I, Stryhn H, Lind P, Collins M (2000). Conditional dependence between tests affects the diagnosis and surveillance of animal diseases. Preventive Veterinary Medicine 45: 107 - 122.

Jones G, Johnson W, Hanson T, Christensen R (2010). Identifiability of models for multiple diagnostic testing in the absence of a gold standard. Biometrics 66: 855 - 863. DOI: 10.1111/j.1541-0420.2009.01330.x.

Martin S, Meek A, Willeberg P (1987). Veterinary Epidemiology Principles and Methods. Iowa State University Press Ames.

Toft N, Akerstedt J, Tharaldsen J, Hopp P (2007). Evaluation of three serological tests for diagnosis of Maedi-Visna virus infection using latent class analysis. Veterinary Microbiology 120: 77 - 86.

Examples

## EXAMPLE 1:
## You would like to confirm the absence of disease in a study area. You 
## intend to use two tests: the first has a sensitivity and specificity of 
## 0.90 and 0.80, respectively. The second has a sensitivity and specificity 
## of 0.95 and 0.85, respectively. You need to make sure that an individual
## that returns a positive test really has disease, so the tests will be 
## interpreted in series (to improve specificity). 

## What is the diagnostic sensitivity and specificity of this testing 
## regime? 

rsu.dxtest(se = c(0.90,0.95), sp = c(0.80,0.85), covar.pos = 0, covar.neg = 0,
   interpretation = "series")
   
## Interpretation of these tests in series returns a diagnostic sensitivity
## of 0.855 and a diagnostic specificity of 0.970.


## EXAMPLE 2 (from Dohoo, Martin and Stryhn p 113):
## An IFAT and PCR are to be used to diagnose infectious salmon anaemia. 
## The diagnostic sensitivity and specificity of the IFAT is 0.784 and 0.951, 
## respectively. The diagnostic sensitivity and specificity of the PCR is 
## 0.926 and 0.979, respectively. It is known that the two tests are dependent, 
## with details of the covariance calculated above. What is the expected 
## sensitivity and specificity if the tests are to be interpreted in parallel?   

rsu.dxtest(se = c(0.784,0.926), sp = c(0.951,0.979), covar.pos = 0.035, 
   covar.neg = -0.001, interpretation = "parallel")

## Interpreting test results in parallel and accounting for the lack of 
## test indepdendence returns a diagnostic sensitivity of 0.949 and diagnostic 
## specificity of 0.930. 


## EXAMPLE 3:
## Three diagnostic tests for Brucella suis in dogs are available: the Rose
## Bengal test (RBT), complement fixation (CFT) and an c-ELISA. The diagnostic
## sensitivities of the three tests are 0.869, 0.873 and 0.897, respectively.
## The diagnostic specificities of the three tests are 0.895, 0.905, and 0.915, 
## respectively.

## For disease positive groups the covariance between test results are 
## as follows:

## RBT - CFT: 0.071
## RBT - c-ELISA: 0.018
## CFT - c-ELISA: 0.015
## RBT - CFT - c-ELISA: -0.001

covp012 <- 0.071
covp013 <- 0.018
covp023 <- 0.015
covp123 <- -0.001
covp <- c(covp012,covp013,covp023,covp123)

## For disease negative groups the covariance between test results are 
## as follows:

## RBT - CFT: 0.076
## RBT - c-ELISA: 0.062
## CFT - c-ELISA: 0.062
## RBT - CFT - c-ELISA: 0.049

covn012 <- 0.076
covn013 <- 0.062
covn023 <- 0.062
covn123 <- 0.049
covn <- c(covn012,covn013,covn023,covn123)

## What is the expected diagnostic sensitivity and specificity if all three 
## tests are run on an individual and interpreted in parallel?

rsu.dxtest(se = c(0.869,0.873,0.897), sp = c(0.895,0.905,0.915), 
   covar.pos = covp, covar.neg = covn, interpretation = "parallel")

## Interpreting the test results in parallel and accounting for depdendence 
## between the three tests returns a diagnostic sensitivity of 
## 0.991 and a diagnostic specificity of 0.873. If we didn't account for test
## dependence our estimate of diagnostic specificity would be 0.741.

## What is the expected sensitivity and specificity if all three 
## tests are run on an individual and interpreted in series?

rsu.dxtest(se = c(0.869,0.873,0.897), sp = c(0.895,0.905,0.915), 
   covar.pos = covp, covar.neg = covn, interpretation = "series")
   
## Interpreting the test results in series and accounting for depdendence 
## between the three tests returns a diagnostic sensitivity of 
## 0.774 and a diagnostic specificity of 1.000.


epiR documentation built on Sept. 30, 2024, 9:16 a.m.